Pharmafile Logo

Innovative Trials

Innovative Trials is a prominent international company specializing in patient recruitment and retention for clinical trials. Boasting 15 years of experience, Innovative Trials provides three fundamental services in this domain:

  • 1:1 In-country Recruitment Coaching & Site Support, facilitated by in-country patient recruitment experts operating in more than 70 countries,
  • Site & Patients Educational Materials,
  • Navigator, a patient support center for referral pre-screening & retention 

With expertise in over 400 trials, 30 therapeutic areas, and over 100 conditions, Innovative Trials has established itself as a trusted and seasoned partner for pharmaceutical companies, contract research organizations (CROs) and biotechnology companies. For more information, visit www.innovativetrials.com

Innovative Trials Ltd, Innovative House, Avenue One, Letchworth Garden City, Hertfordshire, SG6 2WW, United Kingdom

AstraZeneca and Merck decision to disinvest in the UK is a ‘tragedy’ for British research and innovation

Kate Shaw comments on the latest news about AstraZeneca and Merck's decision to hold planned investments in the UK

Innovative Trials names Hertfordshire hospice as 2025 UK charity partner

Innovative Trials, an internationally renowned clinical trials patient recruitment company based in the UK, has today announced Garden House Hospice Care as its UK charity partner for 2025/26. It continues...

Free Live Webinar – Patient Recruitment & Retention

Join Innovative Trials and Soglia in this new patient recruitment and retention webinar!

Innovative Trials appoints first Non-Executive Chair

John Watkinson is the new Non-Exec Chair as Innovative Trials targets significant business growth

Innovative Trials celebrates success for its groundbreaking Retention Patch Program

Innovative Trials attended the PME Award Gala Dinner last night (21st November 2024)

Innovative Trials named a top UK women-powered company in clinical research by J.P. Morgan

Innovative Trials has been named the second-fastest-growing, women-powered UK company in clinical research and ranks among the top 200 women-powered businesses in the UK!

Innovative Trials named a finalist at the PME Award

Patient recruitment and retention company, Innovative Trials, was shortlisted as a finalist in the PME Award for its collaboration with US non-profit Oliver Patch Project to improve patient outcomes.

Innovative Trials appoints new Leadership Team member

Patient Recruitment company, Innovative Trials, appointed new Finance and Business Services Director

Innovative Trials’ CEO wins Women in Pharma Award

Kate Shaw, founder and CEO of Innovative Trials, a global clinical trial patient recruitment and retention company, won the ‘Woman in Pharma’ at the Pharma Industry Awards UK. She was...

Innovative Trials nominated finalist at the Pharma Industry Award

Patient recruitment company, Innovative Trials, has been nominated as a finalist in 2 categories at the Pharma Industry Award Read the full press release 👉🏽 https://bit.ly/3MdzBwf

Patient Recruitment in Oncology: A Phase III Melanoma Case Study

Boosting screening & enrollment rates in a global oncology trial

Mastering Patient Recruitment: A Framework of Five Essential Strategies Developed Over 15 Years

Clinical trial patient recruitment and retention practices have significantly advanced over the last 15 years thanks to technological innovations and the rise of AI, shifting patient expectations and the increased,...

The Impact of AI on Clinical Trials: Four Key Benefits and Three Major Risks

Artificial intelligence (AI) in clinical research has the potential to accelerate patient access to new treatments by streamlining the drug development process and helping to generate more robust data, which...

Three Key Trends Shaping the Future of Clinical Trials

So far this year, we have witnessed several announcements that could have a major impact on the clinical trials market and our global health overall.

Education urgently needed to reverse lack of women-only clinical trials

Kate Shaw, founder and CEO of Innovative Trials, has responded to data that shows the UK has far fewer women-only clinical trials compared to male-only studies. Read the full article here.

Seven strategic steps to enhance patient recruitment & retention in your influenza studies

The development of all treatments, including vaccines, is dependent on people taking part in clinical trials but this can be challenging for influenza studies, especially given the typically short patient...

Movember 2024 – Men’s Health

This Movember, Innovative Trials are raising awareness about men’s health issues like prostate cancer, testicular cancer, and mental health.

Is your influenza clinical trial prepared for the upcoming flu season? Part 3

This blog will discuss some important aspects to consider to maximise patient retention on your flu clinical trials. For more information on patient recruitment considerations, check out our previous blogs...

Is your influenza clinical trial prepared for the upcoming flu season? Part 2

Around 86% of clinical trials do not meet patient recruitment goals, ultimately failing to improve patient outcomes and resulting in financial losses for sponsors and research sites (Rangu and Maxwell,...

Is your influenza clinical trial prepared for the upcoming flu season? Part 1

The Northern Hemisphere flu season is fast approaching, bringing with it a multitude of challenges for respiratory clinical trials. The exact dates of the flu season in the Northern Hemisphere...

Innovative Trials celebrates its 15th anniversary

🎉 Cheers to 15 years of patient recruitment and retention innovation and impact at Innovative Trials! 🎉 From 2010 to 2025, we’ve been on an incredible journey of growth, impact,...

Uniting Communities for Rare Disease Clinical Trial Success

Step into the realm of innovation and collaboration in patient recruitment and retention with our upcoming webinar, "Bridging Boundaries: Uniting Communities for Rare Disease Clinical Trial Success." Delve deep into...

Patient Recruitment & Retention Strategies in the 2024 Clinical Trial Landscape

In the landscape of the clinical trial industry in 2024, persistent challenges persist in the realms of patient recruitment and retention. These hurdles, having endured over several years, continue to...

Solving your biggest patient recruitment and retention challenges

Clinical trial patient recruitment and retention remains one of the key challenges to successfully bringing a new therapeutic to market. An estimated 85% of clinical trials face delays due to...

Retention Patch Program

A partnership between Innovative Trials and the non-profit Oliver Patch Project to boost retention in pediatric studies

Navigating patients step by step on their clinical trial journey

For clinical trial participants, navigating their way through a study can sometimes seem daunting and complicated. Without the right support, around 30% are likely to drop out [1], resulting in...

Patient Recruitment: Think Global, Act Local

Global clinical trials are a vital component of pharma R&D. Utilizing sites in multiple countries not only provides increased access to eligible and diverse patients - and therefore more robust...

Overcoming Patient Recruitment Challenges in Rare Disease Trials

Rare diseases are thought to affect up to 446 million people worldwide. With more than 7,000 rare diseases, most of which are genetic, it’s vital all patients can access new...

Innovative Trials opens first US office

We are incredibly excited to announce the opening of our very first US office! This is an incredible milestone towards our mission to accelerate clinical development. Read the full press...

Equality and Diversity Commitment

Innovative Trials is committed to ensuring we eliminate discrimination from all of our processes and culture. Our Equality and Diversity Committee is here to support the company in creating an organisation where the working environment is accessible, responsive and appropriate to people where all employees can fully contribute, develop and flourish at work, irrespective of their personal characteristics.

Our commitment is to :

  • Take an overview of equality, diversity and human rights issue to support the company’s strategic agenda in this area.
  • Work within Equality and Human Rights Commission guidelines and codes of practice.
  • To oversee the design, implementation and periodic review of IT’s equality objectives.
  • To oversee the implementation, completion, monitoring, audit and evaluation of the Equality Impact Assessment (EqIA) process for policy and procedures.

Eloise Moffett

Eloise Moffett
Vice President of Commercial
+1 984 212 2079

Laura Burt

Laura Burt
Director of Operations
+44 (0) 1707 682 287

Marco Lassandro

Marco Lassandro
Head of Marketing
+44 (0) 1707 959 525

Kate Shaw

Kate Shaw
Founder and CEO
+44 (0) 1707 378 581

Company Details

 Latest Content from  Innovative Trials 

AstraZeneca and Merck decision to disinvest in the UK is a ‘tragedy’ for British research and innovation

Kate Shaw comments on the latest news about AstraZeneca and Merck's decision to hold planned investments in the UK

Patient Recruitment in Oncology: A Phase III Melanoma Case Study

Boosting screening & enrollment rates in a global oncology trial

Mastering Patient Recruitment: A Framework of Five Essential Strategies Developed Over 15 Years

Clinical trial patient recruitment and retention practices have significantly advanced over the last 15 years thanks to technological innovations and the rise of AI, shifting patient expectations and the increased,...

The Impact of AI on Clinical Trials: Four Key Benefits and Three Major Risks

Artificial intelligence (AI) in clinical research has the potential to accelerate patient access to new treatments by streamlining the drug development process and helping to generate more robust data, which...

Three Key Trends Shaping the Future of Clinical Trials

So far this year, we have witnessed several announcements that could have a major impact on the clinical trials market and our global health overall.

Innovative Trials names Hertfordshire hospice as 2025 UK charity partner

Innovative Trials, an internationally renowned clinical trials patient recruitment company based in the UK, has today announced Garden House Hospice Care as its UK charity partner for 2025/26. It continues...

Education urgently needed to reverse lack of women-only clinical trials

Kate Shaw, founder and CEO of Innovative Trials, has responded to data that shows the UK has far fewer women-only clinical trials compared to male-only studies. Read the full article here.

Free Live Webinar – Patient Recruitment & Retention

Join Innovative Trials and Soglia in this new patient recruitment and retention webinar!

Innovative Trials celebrates its 15th anniversary

🎉 Cheers to 15 years of patient recruitment and retention innovation and impact at Innovative Trials! 🎉 From 2010 to 2025, we’ve been on an incredible journey of growth, impact,...

Innovative Trials appoints first Non-Executive Chair

John Watkinson is the new Non-Exec Chair as Innovative Trials targets significant business growth